Zydus Lifesciences on Saturday said its innovative drug has received approval from China's National Medical Products ...

AHMEDABAD, India and NEW YORK, Nov. 26, 2025 /PRNewswire/ -- Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, today announced that it ...

NPPA asks Bayer Zydus Pharma to continue selling Urografin for one more year: Gireesh Babu, New Delhi Thursday, March 5, 2026, 08:00 Hrs [IST] The National Pharmaceutical Pricing ...

Zydus Lifesciences and its wholly owned subsidiary, Zydus Lifesciences Global FZE, have entered into an exclusive licensing and supply agreement with Synthon BV of the Netherlands for ozanimod ...

Shire Human Genetic Therapies and other plaintiffs filed a patent infringement lawsuit against Zydus Lifesciences Global FZE and its affiliated companies on Dec. 19 in Delaware District Court over ...

Stocks like Reliance Industries, Tata Motors, Andhra Cements, Sun Pharmaceutical Industries, Rail Vikas Nigam, Gujarat Mineral Development Corporation, Axiscades Technologies, Power Mech Projects, ...

Brokerage firm Choice Institutional Equities expects a mixed quarter for pharmaceutical companies in Q2 FY26, with domestic operations likely to outperform even as growth in the US moderates. The ...

Several Indian pharmaceutical companies including Glenmark, Granules India, Sun Pharma, Zydus and Unichem are recalling medicines from the US market, according to the US Food and Drug Administration ...

ChemoCentryx, a part of Amgen, filed a patent infringement lawsuit against Zydus Pharmaceuticals on Jan. 16 in New Jersey District Court over Zydus's attempt to market a generic version of Tavneos, a ...

Saion Mukherjee, Managing Director & Head of Equity Research at Nomura says Indian pharmaceutical companies are preparing to ...